Rising incidence of sports injuries especially in children is anticipated to stimulate growth in the global fluoroscopy c-arms market. Fortune Business Insights in a report, titled “Fluoroscopy C-arms Market Size, Share and Global Trend by Product (Mobile c-arms, Full-size c-arms, Mini size C-arms.), By Application (Image-guided biopsy, Angiography, Discography), By End User (Hospitals, Diagnostic centres, Specialty clinics), and Geography Forecast till 2026,” offers a detailed overview of the trends prevailing in the market.
Get PDF Brochure of this [email protected] https://www.fortunebusinessinsights.com/enquiry/sample/fluoroscopy-c-arms-market-100317
As per research studies, around 30 million children in the U.S. alone participate in different types of sports every year. This will give rise to the increase in the incidence of sports injuries, which is expected to drive the market in the forecast years.
North America Registers Highest Growth Owing to Launch of Innovative Products
In 2017, North America covered the highest share in the global fluoroscopy c-arms market. The region is expected to lead the market with the launch of flat panel detectors and other innovative products. New technological advancements in fluoroscopy c-arm machine such as fluoroscopy mini c-arm and mobile c-arm is likely to drive the market in North America. In addition to this, rising investment in healthcare infrastructure and awareness about the advanced imaging systems are likely to create growth opportunities in the market by 2026.
The market in Asia Pacific is anticipated to witness substantial growth during the forecast years. Factors such as better reimbursement policies by insurers and hospitals are likely to spur growth in the market. In addition to this, improving healthcare infrastructure is expected to encourage growth in the market in this region.
Rising Prevalence of Cardiovascular Disorders Stimulates Growth in the Market
“Rising awareness about interventional surgeries is expected to encourage people to get fluoroscopy test done,” stated a lead analyst at Fortune Business Insights. “Rising investments in healthcare sector especially in emerging countries are further expected to augment demand for advanced imaging technology,” she added. These factors are anticipated to encourage growth in the market between 2018 and 2026.
The rising prevalence of cardiovascular diseases is increasing demand for fluoroscopy machines in cardiology surgeries. Moreover, the procedures performed by fluoroscopy machine include percutaneous coronary interventions, coronary angiography and diagnostic electrophysiology studies. This, coupled with rising demand for minimally-invasive surgeries, is likely to boost the market by 2026.
Novel fluoroscopy systems offer high-quality images and are equipped with spectral shaping filters and advanced image intensifiers. Spurred by this factor, the reports predict a promising future for the growth of the global fluoroscopy c-arms market.
Request Customization of this [email protected] https://www.fortunebusinessinsights.com/enquiry/customization/fluoroscopy-c-arms-market-100317
Availability of Substitutes May Hamper the Growth of the Market
Certain factors inhibiting the growth of the market include high costs associated with fluoroscopy devices and lack of reimbursement policies. Another factor restraining the market’s growth is the availability of substitutes for medical imaging procedures. Furthermore, lack of healthcare professionals such as fluoroscopy c-arm operators especially in merging countries is expected to act as stumbling blocks for the growth of the market.
Companies Develop Advanced Products to Ensure User Convenience
In 2019, Koninklijke Philips N.V. launched a new mobile c-arm series called Zenition 50 and Zenition 70 for enhancing workflow efficiency and performance. Companies are focussing on to develop new fluoroscopy devices, enabled with advanced technological features. For instance, Orthoscan launched a new mini c-arm device called TAU 2020 in February 2019 and updated its company branding. Siemens Healthcare introduced a new mobile c-arm device called cios alpha in April 2018. The product was developed to increase precision in surgeries. The mounting costs of fluoroscopy machines is likely to lead to a strong competition amongst market leaders.
Some of the other leading players operating in the global fluoroscopy c-arms market are General Electric Company, Ziehm Imaging GmbH, Hologic, Inc., Hitachi, Ltd., and TOSHIBA CORPORATION.
· Image-guided biopsy
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)